SPARC and cancer: SPARC produced by stromal and immune cells may exert diversified influences over the neoplastic clone, the former contributing to cancer stromatogenesis and stromal remodelling while the latter normalizing the inflammatory milieu by negatively regulating immune cell infiltration and activation (e.g., through suppression of the NF-kB pathway) [75, 88].